Benjamin Brafman writes: I accompanied Martin Shkreli to a congressional hearing on pharmaceutical pricing that he was compelled to attend, despite advance knowledge that he would invoke his Fifth Amendment privilege. Indeed, in my judgment, the only reason for the committee to force Shkreli to appear in person was to try to publicly humiliate him.
- Hedge Funds Win Judgment Against Deutsche Bank
- Panel Declines Bid to Toss Legal Malpractice Suit
- DiFiore Pledges 'Self-Critical' Analysis of OCA Operations
- 'Gun Just Went Off,' Says Officer on Trial for Fatal Shooting
- Senate Confirms Garcia to Court of Appeals
- Legal Operations Resume in Area of Crane Collapse
In this Special Report from the New York Law Journal, brought to you free by Withum: "Jury Charge Issues Loom in Silver, Skelos Appeals," "Defending Parallel Securities and Commodities Actions," "CFTC Enters the Insider Trading Enforcement Arena," "Analyzing the Impact of SEC's Proposed Uniform Fiduciary Standard" and "NYSE Returns to the Regulatory Beat."
From the FRCP changes and burgeoning software options, here's a look at what's in store for e-discovery in 2016.
Panel Finds Man Convicted of Uncharged Crimes
Discipline for Prisoner's Note to Guard Upheld